AE Wealth Management LLC purchased a new position in shares of GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 26,898 shares of the biotechnology company’s stock, valued at approximately $82,000. Other hedge funds and other institutional investors have also recently made changes to their positions in the […]